A small number of patients with haemangioma need treatment for serious complications such as Kasabach-Merritt syndrome, cardiac failure and obstruction of the airway. We report on the management of an infant with Kasabach-Merritt syndrome.
WhiteC.W., SondheimerH.M., CrouchE.C., WilsonH.M., FanL.L.. Treatment of pulmonary heamangiomatosis with recombinant interferon Alfa-2a.N Engl J Med1989; 320: 1197–200
2.
OrchardP.J., SmithC.M., WoodsW.G., DayD.L., DehnerL.P., ShapiroR.. Treatment of haemangioendotheliomas with alpha interferon.Lancet1989; ii: 56S–7
3.
WhiteC.W., WolfS.J., KoronesD.N., SondheimerH.M., TosiM.F., YuA.. Treatment of childhood angiomatous disease with recombinant interferon Alfa-2a.J Pediatr1991; 118: 59–66
4.
EzekowitzR.A.B., MullikenJ.B., FolkmanJ.. Interferon alpha-2a therapy for life-threatening haemangiomas of infancy.N Engl J Med1992; 22: 1456–63
5.
Teillac-HamelD., De ProstY, BodemerC.Serious childhood angiomas: unsuccessful alpha-2b interferon treatment. A report of 4 cases.Br J Dermatol1993; 129: 473–6
6.
BrandP.L.P., van LingenRA, BrusF., TalsmaM.D., ElzengaN.J.. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.Acta Paediatr1993; 82: 614–17
7.
EvansN.. Cardiovascular effects of dexamethasone in the preterm infant.Arch Dis Child1994; 70: F25–F30
8.
EnjolrasO., RieheM.C., MerlandJ.J., EscandeJ.P.. Management of alarming haemangiomas in infancy: a review of 25 cases.Acta Paediatr1990; 85: 491–8
